LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA. LipidRescue® is a proposed proprietary name that is subject to FDA approval.
LAST is a life-threatening medical complication that occurs when local anesthetics enter the circulation producing potentially severe cardiac and neurological toxicity. It can occur whenever and wherever local anesthetics are used and can result in seizures, cardiovascular instability (irregular heart rhythm, low blood pressure, etc.) and even cardiac arrest. Clinical experience and laboratory data indicate that LipidRescue can treat LAST.
LAST IS THE FIRST INDICATION FOR WHICH RESQ SEEKS FDA APPROVAL OF A LIPIDRESCUE® SAFETY KIT
LAST is a medical emergency that requires immediate care. Basic and advanced life support, includes:
LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA.
LipidRescue® is a proposed proprietary name that is subject to FDA approval.
Website designed by JDW
Copyright © 2021 ResQ Pharma, Inc - All Rights Reserved.
Powered by GoDaddy